Evaluation of a Minimally Invasive Cell Sampling Device Coupled with Assessment of Trefoil Factor 3 Expression for Diagnosing Barrett's Esophagus: A Multi-Center Case–Control Study

• Caryn S. Ross-Innes,

  Affiliation MRC Cancer Unit, Hutchison/MRC Research Centre, University of Cambridge, Cambridge, United Kingdom

  ⨯
• Irene Debiram-Beecham,

  Affiliation MRC Cancer Unit, Hutchison/MRC Research Centre, University of Cambridge, Cambridge, United Kingdom

  ⨯
• Maria O'Donovan,

  Affiliation Department of Histopathology, Addenbrooke's Hospital, Cambridge, United Kingdom

  ⨯
• Elaine Walker,

  Affiliation MRC Cancer Unit, Hutchison/MRC Research Centre, University of Cambridge, Cambridge, United Kingdom

  ⨯
• Sibu Varghese,

  Affiliation MRC Cancer Unit, Hutchison/MRC Research Centre, University of Cambridge, Cambridge, United Kingdom

  ⨯
• Pierre Lao-Sirieix,

  Affiliation MRC Cancer Unit, Hutchison/MRC Research Centre, University of Cambridge, Cambridge, United Kingdom

  ⨯
• Laurence Lovat,

  Affiliation University College London Hospital, London, United Kingdom

  ⨯
• Michael Griffin,

  Affiliation Royal Victoria Infirmary, Newcastle upon Tyne, United Kingdom

  ⨯
• Krish Ragunath,

  Affiliation Nottingham Queen's Medical Centre, Nottingham, United Kingdom

  ⨯
• Rehan Haidry,

  Affiliation University College London Hospital, London, United Kingdom

  ⨯
• Sarmed S. Sami,

  Affiliation Nottingham Queen's Medical Centre, Nottingham, United Kingdom

  ⨯
• Philip Kaye,

  Affiliation Nottingham Queen's Medical Centre, Nottingham, United Kingdom

  ⨯
• Marco Novelli,

  Affiliation University College London Hospital, London, United Kingdom

  ⨯
• Babett Disep,

  Affiliation Royal Victoria Infirmary, Newcastle upon Tyne, United Kingdom

  ⨯
• Richard Ostler,

  Affiliation Cancer Prevention Trials Unit, London, United Kingdom

  ⨯
• Benoit Aigret,

  Affiliation Cancer Prevention Trials Unit, London, United Kingdom

  ⨯
• Bernard V. North,

  Affiliation Cancer Prevention Trials Unit, London, United Kingdom

  ⨯
• Pradeep Bhandari,

  Affiliation Queen Alexandra Hospital, Portsmouth, United Kingdom

  ⨯
• Adam Haycock,

  Affiliation St Mark's Hospital, London, United Kingdom

  ⨯
• Danielle Morris,

  Affiliation East and North Hertfordshire NHS Trust–QEII and Lister Hospitals, Welwyn Garden City and Stevenage, United Kingdom

  ⨯
• Stephen Attwood,

  Affiliations Northern Region Endoscopy Group, United Kingdom, North Tyneside General Hospital, North Shields, United Kingdom

  ⨯
• Anjan Dhar,

  Affiliations Northern Region Endoscopy Group, United Kingdom, County Durham and Darlington NHS Foundation Trust, Durham, United Kingdom

  ⨯
• Colin Rees,

  Affiliations Northern Region Endoscopy Group, United Kingdom, South Tyneside NHS Foundation Trust, South Shields, United Kingdom

  ⨯
• Matthew D. D. Rutter,

  Affiliations Northern Region Endoscopy Group, United Kingdom, North Tees and Hartlepool NHS Foundation Trust, Stockton-on-Tees, United Kingdom

  ⨯
• Peter D. Sasieni,

  Affiliation Cancer Prevention Trials Unit, London, United Kingdom

  ⨯
• Rebecca C. Fitzgerald ,

  * E-mail: rcf29@MRC-CU.cam.ac.uk

  Affiliation MRC Cancer Unit, Hutchison/MRC Research Centre, University of Cambridge, Cambridge, United Kingdom

  ⨯
•  [ ... ],
• on behalf of the BEST2 Study Group

  ¶Membership of the BEST2 Study Group is provided in the Acknowledgments.

  ⨯
• [ view all ]
• [ view less ]